Characterize the news's sentiment using the following options.
Options: positive, negative

Outlook Therapeutics (NASDAQ:OTLK) Inc has said its chief operations officer Terry Dagnon will discuss the company's wet age-related macular degeneration (AMD) drug Lytenava as part of a panel at the 2022 World Retina Conference later this month.  The conference is taking place from May 12-15, 2022, in Fort Lauderdale, Florida.
positive